These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2632719)
1. Regulation of cardiac output during aldosterone-induced hypertension. Montani JP; Mizelle HL; Adair TH; Guyton AC J Hypertens Suppl; 1989 Dec; 7(6):S206-7. PubMed ID: 2632719 [TBL] [Abstract][Full Text] [Related]
2. Hemodynamics and blood volume in angiotensin II salt-dependent hypertension in dogs. Krieger JE; Roman RJ; Cowley AW Am J Physiol; 1989 Nov; 257(5 Pt 2):H1402-12. PubMed ID: 2589496 [TBL] [Abstract][Full Text] [Related]
3. Experimental aldosterone hypertension in the dog. Pan YJ; Young DB Hypertension; 1982; 4(2):279-87. PubMed ID: 7040227 [TBL] [Abstract][Full Text] [Related]
4. Essential role of mean circulatory filling pressure in salt-induced hypertension. Manning RD; Coleman TG; Guyton AC; Norman RA; McCaa RE Am J Physiol; 1979 Jan; 236(1):R40-7. PubMed ID: 434186 [TBL] [Abstract][Full Text] [Related]
5. Baroreceptor reflex effects on transient and steady-state hemodynamics of salt-loading hypertension in dogs. Cowley AW; Guyton AC Circ Res; 1975 Apr; 36(4):536-46. PubMed ID: 1116246 [TBL] [Abstract][Full Text] [Related]
7. Interaction between the natriuretic effects of renal perfusion pressure and the antinatriuretic effects of angiotensin and aldosterone in control of sodium excretion. Young DB; Pan YJ J Physiol (Paris); 1984; 79(6):511-7. PubMed ID: 6399318 [TBL] [Abstract][Full Text] [Related]
8. Haemodynamic effects of increasing extracellular potassium concentration in ACTH-induced hypertension in sheep. Scoggins BA; Coghlan JP; Denton DA; Fitzgerald M; Graham WF; Mason RT; Schneider EG Clin Sci (Lond); 1980 Dec; 59 Suppl 6():373s-376s. PubMed ID: 6256118 [TBL] [Abstract][Full Text] [Related]
9. Aldosterone acts on the kidney, not the brain, to cause mineralocorticoid hypertension in sheep. León LA; McKinley MJ; McAllen RM; May CN J Hypertens; 2002 Jun; 20(6):1203-8. PubMed ID: 12023692 [TBL] [Abstract][Full Text] [Related]
10. Hypertensive mechanisms associated with centrally administered aldosterone in dogs. Kageyama Y; Bravo EL Hypertension; 1988 Jun; 11(6 Pt 2):750-3. PubMed ID: 3391682 [TBL] [Abstract][Full Text] [Related]
11. Hemodynamic and humoral characteristics of hypertension induced by prolonged stellate ganglion stimulation in conscious dogs. Liard JF; Tarazi RC; Ferrario CM; Manger WM Circ Res; 1975 Mar; 36(3):455-64. PubMed ID: 1112001 [TBL] [Abstract][Full Text] [Related]
12. Recurrence of hypertension in primary aldosteronism after discontinuation of spironolactone. Time course of changes in cardiac output and body fluid volumes. Wenting GJ; Man in 't Veld AJ; Derkx FH; Schalekamp MA Clin Exp Hypertens A; 1982; 4(9-10):1727-48. PubMed ID: 6754151 [TBL] [Abstract][Full Text] [Related]
13. Prevention of salt angiotensin II hypertension by servo control of body water. Krieger JE; Cowley AW Am J Physiol; 1990 Apr; 258(4 Pt 2):H994-1003. PubMed ID: 2331020 [TBL] [Abstract][Full Text] [Related]
14. Regional blood flows in salt loading hypertension in the dog. Liard JF Am J Physiol; 1981 Mar; 240(3):H361-7. PubMed ID: 7212079 [TBL] [Abstract][Full Text] [Related]
15. Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterial hypertension. Schlaich MP; Klingbeil AU; Jacobi J; Delles C; Schneider MP; Schmidt BM; Schmieder RE J Hypertens; 2002 Jan; 20(1):117-24. PubMed ID: 11791034 [TBL] [Abstract][Full Text] [Related]